FOXO3-engineered human mesenchymal progenitor cells efficiently promote cardiac repair after myocardial infarction
Jinghui Lei, Si Wang, Wang Kang, Qun Chu, Zunpeng Liu, Liang Sun, Yun Ji, Concepcion Rodriguez Esteban, Yan Yao, Juan Carlos Izpisua Belmonte, Piu Chan, Guang-Hui Liu, Weiqi Zhang, Moshi Song, Jing Qu
FOXO3-engineered human mesenchymal progenitor cells efficiently promote cardiac repair after myocardial infarction
[1] |
Bagno L, Hatzistergos KE, Balkan W, Hare JM (2018) Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges. Mol Ther 26:1610–1623
CrossRef
Google scholar
|
[2] |
Block TJ, Marinkovic M, Tran ON, Gonzalez AO, Marshall A, Dean DD, Chen XD (2017) Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies. Stem Cell Res Ther 8:239
CrossRef
Google scholar
|
[3] |
De Cecco M, Ito T, Petrashen AP, Elias AE, Skvir NJ, Criscione SW, Caligiana A, Brocculi G,Adney EM, Boeke JD
CrossRef
Google scholar
|
[4] |
Gyongyosi M, Haller PM, Blake DJ, Martin ERendon (2018) Metaanalysis of cell therapy studies in heart failure and acute myocardial infarction. Circ Res 123:301–308
CrossRef
Google scholar
|
[5] |
Kanelidis AJ, Premer C, Lopez J, Balkan W, Hare JM (2017) Route of delivery modulates the efficacy of mesenchymal stem cell therapy for myocardial infarction: a meta-analysis of preclinical studies and clinical trials. Circ Res 120:1139–1150
CrossRef
Google scholar
|
[6] |
Le Blanc K, Davies LC (2018) MSCs-cells with many sides. Cytotherapy 20:273–278
CrossRef
Google scholar
|
[7] |
Li L, Kang H, Zhang Q, D’Agati VD, Al-Awqati Q, Lin F (2019) FoxO3 activation in hypoxic tubules prevents chronic kidney disease. J Clin Investig 129:2374–2389
CrossRef
Google scholar
|
[8] |
Li H, Wu Z, Liu X, Zhang S, Ji Q, Jiang X, Liu Z, Wang S, Qu J, Zhang W
CrossRef
Google scholar
|
[9] |
Lim SW, Jin L, Luo K, Jin J, Shin YJ, Hong SY, Yang CW (2017) Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress. Cell Death Dis 8: e2972
CrossRef
Google scholar
|
[10] |
Liu Y, Ao X, Ding W, Ponnusamy M, Wu W, Hao X, Yu W, Wang Y, Li P, Wang J (2018) Critical role of FOXO3a in carcinogenesis. Mol Cancer 17:104
CrossRef
Google scholar
|
[11] |
Nguyen PK, Neofytou E, Rhee JW, Wu JC (2016) Potential strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease: a review. JAMA Cardiol 1:953–962
CrossRef
Google scholar
|
[12] |
Salazar-Noratto GE, Luo G, Denoeud C, Padrona M, Moya A, Bensidhoum M, Bizios R, Potier E, Logeart-Avramoglou D, Petite H (2020) Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications. Stem Cells 38:22–23
CrossRef
Google scholar
|
[13] |
Wang P, Liu Z, Zhang X, Li J, Sun L, Ju Z, Li J, Chan P, Liu GH, Zhang W
CrossRef
Google scholar
|
[14] |
Yan P, Li Q, Wang L, Lu P, Suzuki K, Liu Z, Lei J, Li W, He X, Wang S
CrossRef
Google scholar
|
[15] |
Zhang W, Zhang S, Yan P, Ren J, Song M, Li J, Lei J, Pan H, Wang S, Ma X
CrossRef
Google scholar
|
/
〈 | 〉 |